| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61314-325-20 | 61314-325 | HUMAN PRESCRIPTION DRUG | Adalimumab | adalimumab-adaz | INJECTION, SOLUTION | SUBCUTANEOUS | 20250106 | N/A | BLA | BLA761071 | Sandoz Inc | ADALIMUMAB | 80 mg/.8mL | 2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE |
| 83457-100-01 | 83457-100 | HUMAN PRESCRIPTION DRUG | HYRIMOZ | adalimumab-adaz | INJECTION, SOLUTION | SUBCUTANEOUS | 20230921 | N/A | BLA | BLA761071 | Cordavis Limited | ADALIMUMAB | 40 mg/.4mL | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE |
| 83457-101-01 | 83457-101 | HUMAN PRESCRIPTION DRUG | HYRIMOZ | adalimumab-adaz | INJECTION, SOLUTION | SUBCUTANEOUS | 20230921 | N/A | BLA | BLA761071 | Cordavis Limited | ADALIMUMAB | 40 mg/.4mL | 2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS |